Bothrojaracin, a Bothrops jararaca snake venom-derived (Pro)thrombin inhibitor, as an anti-thrombotic molecule

Pathophysiology of Haemostasis and Thrombosis

Volumn 34, Issue 4-5, 2006, Pages 160-163

  Zingali, Russolina B ^a   Ferreira, Marcos S ^a   Assafim, Mariane ^a   Frattani, Flávia S ^a   Monteiro, Robson Q ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Anti thrombotic effects; Bothrojaracin; Prothrombin; Snake venom; Thrombin

Indexed keywords

ANTICOAGULANT AGENT; BOTHROJARACIN; COMPLEMENTARY DNA; GLYCYRRHIZIC ACID; HEPARIN; PROTHROMBIN; THROMBIN; THROMBIN INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; BINDING SITE; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; DRUG EFFECT; DRUG MECHANISM; HEMOSTASIS; HYPERCOAGULABILITY; LUNG EMBOLISM; MOUSE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTHROMBIN TIME; RAT; SNAKE; SURVIVAL RATE; THROMBOEMBOLISM; THROMBOSIS PREVENTION; TREATMENT OUTCOME;

ANIMALS; CROTALID VENOMS; HUMANS; MURINAE; SNAKE VENOMS; THROMBIN; VENOUS THROMBOSIS;

EID: 33646778159     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092416     Document Type: Conference Paper

References (28)

1. Stocker KF (ed): Medical Use of Snake Venom Proteins. Boca Raton, USA, CRC Press, 1990, p 272.
2. Markland FS: Snake venoms and the hemostatic system. Toxicon 1998;36:1749-1800.
3. Braud S, Bon C, Wisner A: Snake venom proteins acting on hemostasis. Biochimie 2000;82:851-859.
4. Zingali RB, Jandrot-Perrus M, Guillin MC, Bon C: Bothrojaracin, a new thrombin inhibitor isolated from Bothrops jararaca venom: characterization and mechanism of thrombin inhibition. Biochemistry 1993;32:10794-10802.
5. Arocas V, Castro HC, Zingali RB, Guillin MC, Jandrot-Perrus M, Bon C, Wisner A: Molecular cloning and expression of bothrojaracin, a potent thrombin inhibitor from snake venom. Eur J Biochem 1997;248:550-557.
6. Usami Y, Fujimura Y, Suzuki M, Ozeki Y, Nishio K, Fukui H, Titani K: Primary structure of two-chain botrocetin, a von Willebrand factor modulator purified from the venom of Bothrops jararaca. Proc Natl Acad Sci USA 1993;90:928-932.
7. Sekiya F, Atoda H, Morita T: Isolation and characterization of an anticoagulant protein homologous to botrocetin from the venom of Bothrops jararaca. Biochemistry 1993;32:6892-6897.
8. Kawasaki T, Fujimura Y, Usami Y, Suzuki M, Miura S, Sakurai Y, Makita K, Taniuchi Y, Hirano K, Titani K: Complete amino acid sequence and identification of the platelet glycoprotein Ib-binding site of jararaca GPIb-BP, a snake venom protein isolated from Bothrops jararaca. J Biol Chem 1996;271:10635-10639.
9. Koh Y, Chung K, Kim D: Purification and cDNA cloning of salmorin that inhibits fibrinogen clotting. Thromb Res 2000;99:389-398.
10. Atoda H, Kaneko H, Mizuno H, Morita T: Calcium-binding analysis and molecular modeling reveal Echis coagulation factor IX/factor X-binding protein has the Ca-binding properties and Ca ion-independent folding of other C-type lectin-like proteins. FEBS Lett 2002;531:229-234.
11. Monteiro RQ, Carlini CR, Guimarães JA, Zingali RB: Distinct bothojaracin isoforms produced by individual jararaca (Bothrops jararaca) snakes. Toxicon 1997;35:649-657.
12. Monteiro RQ, Dutra DLS, Machado OLT, Carlini CR, Guimarães JA, Bon C, Zingali RB: Bothrops jararaca snakes produce several bothrojaracin isoforms following an individual pattern. Comp Biochem Physiol B 1998;120:791-798.
13. Castro HC, Dutra DLS, Oliveira-Carvalho AL, Zingali RB: Bothroalternin, a thrombin inhibitor from the venom of Bothrops alternatus. Toxicon 1998;36:1903-1912.
14. Castro HC, Fernandes M, Zingali RB: Identification of bothrojaracin-like proteins in snake venoms from Bothrops species and Lachesis muta. Toxicon 1999;37:1403-1416.
15. Castro HC, Lemos MG, Bon C, Zingali RB: Comparative evaluation of immunological and structural similarities of snake venom C-type lectin proteins. Toxicon 2003;41:525-528.
16. Arocas V, Zingali RB, Guillin MC, Bon C, Jandrot-Perus M: Bothrojaracin: a potent two-site-directed thrombin inhibitor. Biochemistry 1996;35:9083-9089.
17. Arocas V, Lemaire C, Bouton MC, Beazeaud A, Bon C, Guillin MC, Jandrot-Perrus M: Inhibition of thrombin-catalysed factor V activation by bothrojaracin. Thromb Haemost 1998;79:1157-1161.
18. Monteiro RQ, Rapôso JG, Wisner A, Guimarães JA, Bon C, Zingali RB: Allosteric changes of thrombin catalytic site induced by interaction of bothrojaracin with anion-binding exosities I and II. Biochem Biophys Res Commun 1999;262:819-822.
19. Zingali RB, Bianconi ML, Monteiro RQ: Interaction of bothrojaracin with prothrombin. Haemostasis 2001;31:273-278.
20. Monteiro RQ, Zingali RB: Inhibition of prothrombin activation by bothrojaracin, a C-type lectin from Bothrops jararaca venom. Arch Biochem Biophys 2000;382:123-128.
21. Anderson PJ, Nesset A, Dharmawardana KR, Bock PE: Role of proexosite I in factor Va-dependent substrate interactions of prothrombin activation. J Biol Chem 2000;275:16435-16442.
22. Monteiro RQ, Bock PE, Bianconi ML, Zingali RB: Characterization of bothrojaracin interaction with human prothrombin. Protein Sci 2001;10:1897-1904.
23. Speijer H, Govers-Riemslag JW, Zwaal RF, Rosing J: Prothrombin activation by an activator from the venom of Oxyuranus scutellatus (Taipan snake). J Biol Chem 1986;261:13258-13267.
24. Monteiro RQ, Zingali RB: Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation. Thromb Haemost 2002;87:288-293.
25. Hirsh J, Warkentin TE, Shaughnessy SG, Anand SS, Halperin JL, Raschke R, Granger C, Ohman EM, Dalem JE: Heparin and low molecular weight heparin: mechanism of action, pharmacokinetics, dosing, monitoring, efficacy and safety. Chest 2001;119:64S-94S.
26. Mendes-Silva W, Assafim M, Ruta B, Monteiro RQ, Guimarães JA, Zingali RB: Anti-thrombotic effect of Glycyrrhizin, a plant-derived thrombin inhibitor. Thromb Res 2003;112:93-98.
27. Herbert JM, Hérault JP, Bernat A, Van Amsterdan RGM, Vogel GMT, Lormeau JC: Biochemical and pharmacological properties of SANORG 32701. Comparison with the 'synthetic pentasacharide (SR90107/org 31549)' and standard heparin. Circ Res 1996;79:590-600.
28. Gresele P, Momi S, Berrettini M, Nenci GG, Schwarz HP, Semeraro N, Colluci M: Activated human protein C prevents thrombin-induced thromboembolism in mice. J Clin Invest 1998;101:667-676.